Abstract
After surgery for cancer of the spine, follow-up care to detect recurrence is an expected part of the overall postoperative care. Components of disease-free surveillance include periodic physical examinations, radiological studies, and blood work to follow or detect tumor markers. Establishing standards for routine follow-up may be difficult owing to the variability of cancers involving the spine (low-grade sarcomas, high-grade sarcomas, and metastatic disease) and the extent of involvement throughout the spine or body.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Grunfeld E, Gray A, Mant D, et al. Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation. Br J Cancer 1999; 79:1227–1233.
Grunfeld E, Mant D, Yudkin P, et al. Routine follow up of breast cancer in primary care: randomised trial. BMJ 1996; 313:665–669.
Winn RJ. The role of oncology clinical practice guidelines in the managed care era. Oncology (Huntingt) 1995; 9:177–183.
Smith RA, Cokkinides V, von Eschenbach AC, et al. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2002; 52:8–22.
Smith TJ, Somerfield MR. The ASCO experience with evidence-based clinical practice guidelines. Oncology (Huntingt) 1997; 11:223–227.
American Society of Clinical Oncology. Recommended breast cancer surveillance guidelines. J Clin Oncol 1997; 15:2149–2156.
Grunfeld E, Mant D, Vessey MP, Fitzpatrick R. Specialist and general practice views on routine follow-up of breast cancer patients in general practice. Fam Pract 1995; 12:60–65.
Lelli G, Indelli M, Modonesi C, Gulmini L, Durante E. [Clinical postoperative surveillance of breast carcinoma]. Recenti Prog Med 2002; 93:637–641.
Levin M. Breast cancer: issues in risk reduction, screening and surveillance, early identification and therapy planning. Drug News Perspect 2003; 16:395–398.
Truong PT, Olivotto IA, Whelan TJ, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ 2004; 170:1263–1273.
Smith TJ, Davidson NE, Schapira DV, et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 1999; 17:1080–1082.
American Society of Clinical Oncology. 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology. J Clin Oncol 1998; 16:793–795.
Bast RC, Jr., Ravdin P, Hayes DF, et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19:1865–1878.
Benson AB, III, Desch CE, Flynn PJ, et al. 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol 2000; 18:3586–3588.
Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001—testing for early lung cancer detection. CA Cancer J Clin 2001; 51:38–75.
American Society of Clinical Oncology. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology. J Clin Oncol 1996; 14:2843–2877.
Cooper GS, Yuan Z, Chak A, and Rimm AA. Geographic and patient variation among Medicare beneficiaries in the use of follow-up testing after surgery for nonmetastatic colorectal carcinoma. Cancer 1999; 85:2124–2131.
Desch CE, Benson AB, III, Smith TJ, et al. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol 1999; 17:1312.
Graham RA, Wang S, Catalano PJ, Haller DG. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy. Ann Surg 1998; 228:59–63.
Pfister DG, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004; 22:330–353.
American Society of Clinical Oncology. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology. J Clin Oncol 1997; 15:2996–3018.
Valk PE, Pounds TR, Tesar RD, Hopkins DM, Haseman MK. Cost-effectiveness of PET imaging in clinical oncology. Nucl Med Biol 1996; 23:737–743.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press, Inc., Totowa, NJ
About this chapter
Cite this chapter
Placide, R., Lewandrowski, KU., McLain, R.F. (2006). Surveillance and Screening During Disease-Free Survival. In: McLain, R.F., Lewandrowski, KU., Markman, M., Bukowski, R.M., Macklis, R., Benzel, E.C. (eds) Cancer in the Spine. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-59259-971-4_42
Download citation
DOI: https://doi.org/10.1007/978-1-59259-971-4_42
Publisher Name: Humana Press
Print ISBN: 978-1-58829-074-8
Online ISBN: 978-1-59259-971-4
eBook Packages: MedicineMedicine (R0)